Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22928219 | 0.91 | MEN1 (0.33) | LMNAMAPTL3MBTL1 | |
| SCHEMBL22928357 | 0.88 | C5AR1 (0.34) | NSD2ALDH1A1EGFRLMNAMAPT | |
| SCHEMBL22928288 | 0.87 | KCNA3 (0.30) | KCNA3 | |
| SCHEMBL22928220 | 0.84 | RAB9A (0.33) | ALDH1A1L3MBTL1 | |
| SCHEMBL22928711 | 0.78 | METAP2 (0.30) | — | |
| SCHEMBL22928714 | 0.75 | NPC1 (0.31) | ALDH1A1L3MBTL1 | |
| SCHEMBL26401549 | 0.74 | MEN1 (0.31) | KCNA3LMNAMAPTL3MBTL1 | |
| SCHEMBL22928221 | 0.73 | MEN1 (0.40) | ALDH1A1LMNAMAPTMAPK1TDP1 | |
| SCHEMBL22928233 | 0.72 | MAPT (0.36) | ALDH1A1LMNAMAPTTDP1L3MBTL1 | |
| SCHEMBL21922853 | 0.72 | MAPT (0.55) | NSD2ALDH1A1EGFRLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780831-B2 | Compound, display panel and display apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-11780831-B2 | Compound, display panel and display apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-20210024511-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024511-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | C1S, DRD1, DRD3 | KCNA3 3466/4885NSD2 1688/4885ALDH1A1 135/4885 |
| US-11780831-B2 | Compound, display panel and display apparatus | C1S, DRD1, DRD3 | KCNA3 3466/4885NSD2 1688/4885ALDH1A1 135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.